Regeneron stock hits all-time high of $1115.06 after positive clinical trial results

From Google: 2024-08-09 09:39:27

Regeneron stock reaches all-time high of $1115.06, soaring on positive clinical trial results. Company’s potential Covid-19 treatment shows promise in reducing viral levels. Investors react positively to news, pushing stock price up. Regeneron’s market value reaches over $120 billion. The company continues to focus on developing innovative therapies.



Read more at Google: Regeneron stock soars to all-time high of $1115.06 – Investing.com